— Know what they know.
Not Investment Advice
Also trades as: 0Y6X.L (LSE) · $vol 1M · 2M6.DE (XETRA) · $vol 0M

MDT NYSE

Medtronic Plc
1W: -0.7% 1M: +5.0% 3M: +8.2% YTD: +0.3% 1Y: +3.6% 3Y: +42.6% 5Y: -9.8%
$93.95
-0.84 (-0.89%)
 
Weekly Expected Move ±4.3%
$87 $91 $95 $99 $104
NYSE · Healthcare · Medical - Devices · Tech Score Buy · Power 80 · $120.2B mcap · 1.28B float · 1.11% daily turnover · Short 48% of daily vol
Credit Risk of going bust: lower than 81% of companies Debt: 19.0% of company value Bonds: $175.5M held by 166 funds, 54 bp over Treasuries → details ▾
If the stock fell to about $1.30 (down 99%), Medtronic Plc would be worth roughly what it owes.
Total debt $28.15B against a stock market value of $120.18B.
Distance to default 10.00 (Merton model): prices to 2026-10-27, balance sheet 2026-07-31, debt counted $15.34B (short-term plus half of long-term), stock volatility 24.6%; Altman Z'' 3.81. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WIDE EDGE
83.8 / 100
NoneWeakNarrowWide
Primary source: Cost Advantage  ·  ROIC: 7.8%  ·  5Y Avg: 6.7%
Cost Advantage ★
100
Intangibles
84
Switching Cost
78
Network Effect
70
Scale
85
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. MDT possesses a Wide competitive edge (83.8/100) — durable structural advantages that are difficult for competitors to erode. The primary source of advantage is Cost Advantage. ROIC of 7.8% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$92
Low
$101
Avg Target
$115
High
Based on 9 analysts since Sep 1, 2026 earnings
Analyst Recommendations
Strong Buy: 1Buy: 30Hold: 20Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$102.09
Analysts11
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-10-12 BTIG — $100 $99 -1 +7.1% $92.46
2026-10-06 Barclays — $118 $95 -23 +9.1% $87.09
2026-09-03 Deutsche Bank — $80 $92 +12 +0.5% $91.50
2026-09-03 UBS — $100 $110 +10 +19.3% $92.18
2026-09-02 Mizuho Securities Anthony Petrone $100 $115 +15 +24.8% $92.18
2026-09-02 Stifel Nicolaus Rick Wise $80 $95 +15 +3.2% $92.04
2026-09-02 Wells Fargo Larry Biegelsen $114 $104 -10 +13.0% $92.04
2026-09-02 Truist Financial Richard Newitter $86 $99 +13 +7.6% $92.04
2026-09-01 BTIG — $91 $100 +9 +8.2% $92.44
2026-08-27 Needham — $101 $114 +13 +23.9% $92.02
2026-07-28 UBS Priya Sachdeva $85 $100 +15 +18.7% $84.22
2026-07-13 BTIG Ryan Zimmerman $90 $91 +1 +8.5% $83.87
2026-07-06 Evercore ISI — $106 $105 -1 +28.7% $81.61
2026-06-16 Piper Sandler Matt O'Brien $90 $85 -5 +4.8% $81.14
2026-06-05 Goldman Sachs David Roman $84 $83 -1 +0.9% $82.28
2026-06-04 Truist Financial — $95 $86 -9 +5.3% $81.64
2026-06-04 Bernstein Lee Hambright $112 $97 -15 +17.5% $82.54
2026-06-04 Robert W. Baird David Rescott $100 $85 -15 +9.0% $77.95
2026-06-04 UBS Priya Sachdeva $104 $85 -19 +9.0% $77.95
2026-06-04 Jefferies Matthew Taylor $95 $88 -7 +12.9% $77.95
2026-06-03 BTIG — Initiated $90 — +15.5% $77.95
2026-06-03 Stifel Nicolaus Rick Wise $87 $80 -7 +2.6% $77.95
2026-06-03 Needham Mike Matson $120 $101 -19 +29.4% $78.03
2026-06-03 Mizuho Securities Anthony Petrone $120 $100 -20 +35.6% $73.75
2026-05-21 Goldman Sachs — $111 $84 -27 +7.5% $78.15
2026-04-23 Jefferies Matthew Taylor $110 $95 -15 +13.4% $83.79
2026-04-15 Truist Financial Richard Newitter $107 $95 -12 +9.3% $86.88
2026-04-13 Mizuho Securities — $98 $120 +22 +38.3% $86.75
2026-04-09 Evercore ISI Vijay Kumar $104 $106 +2 +20.6% $87.91
2026-03-10 Leerink Partners Mike Kratky $120 $119 -1 +31.8% $90.31
2026-03-10 Needham Michael Matson $121 $120 -1 +33.0% $90.21
2026-02-18 Robert W. Baird — $103 $100 -3 +3.7% $96.41
2026-02-18 Barclays Matt Miksic $116 $118 +2 +22.4% $96.41
2026-02-09 Needham — $124 $121 -3 +17.6% $102.90
2026-02-04 UBS — $135 $104 -31 +0.6% $103.38
2026-01-30 Wells Fargo Larry Biegelsen $106 $114 +8 +12.0% $101.78
2026-01-09 Bernstein — $111 $112 +1 +13.5% $98.69
2026-01-08 Barclays Matt Miksic $111 $116 +5 +16.3% $99.77
2025-12-18 Truist Financial Richard Newitter $103 $107 +4 +7.9% $99.14
2025-12-16 Robert W. Baird — $96 $103 +7 +4.4% $98.67
2025-11-20 Barclays — $85 $111 +26 +10.6% $100.34
2025-11-19 Bernstein Lee Hambright $98 $111 +13 +10.6% $100.34
2025-11-19 Leerink Partners Mike Kratky Initiated $120 — +19.0% $100.80
2025-11-19 Jefferies Matthew Taylor $155 $110 -45 +9.1% $100.80
2025-11-19 Goldman Sachs David Roman $82 $111 +29 +10.1% $100.80
2025-10-31 Bernstein Lee Hambright $93 $98 +5 +7.5% $91.17
2025-10-15 Truist Financial — $88 $103 +15 +8.1% $95.26
2025-10-10 RBC Capital — $105 $111 +6 +16.0% $95.72
2025-08-26 Argus Research David Toung $165 $115 -50 +24.8% $92.18
2025-01-08 Bernstein Lee Hambright Initiated $93 — +12.5% $82.68

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
Oct 27, 2026
DCF
4
ROE
3
ROA
4
D/E
2
P/E
3
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. MDT receives an overall rating of B+. Strongest factors: DCF (4/5), ROA (4/5). Areas of concern: D/E (2/5).
Rating Change History
DateFromTo
2026-10-01 A- B+
2026-09-04 B- A-
2026-09-01 A- B-
2026-08-10 B+ A-
2026-07-01 A- B+
2026-06-18 C A-
2026-06-03 A- C
2026-05-11 B+ A-
2026-05-04 B B+
2026-04-28 B+ B

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 64 Grade A+
Profitability
57
Balance Sheet
70
Earnings Quality
93
Growth
55
Value
64
Momentum
83
Safety
65
Cash Flow
66
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. MDT scores highest in Earnings Quality (93/100) and lowest in Growth (55/100). An overall grade of A+ places MDT among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.86
Grey Zone
Piotroski F-Score
9/9
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Beneish M-Score
-3.44
Unlikely Manipulator
Ohlson O-Score
-9.52
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A
Score: 74.1/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.54x
Accruals: -3.0%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. MDT scores 2.86, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. MDT scores 9/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. MDT's score of -3.44 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. MDT's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. MDT receives an estimated rating of A (score: 74.1/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). MDT's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
22.97x
PEG
1.81x
P/S
3.20x
P/B
2.39x
P/FCF
17.75x
P/OCF
13.55x
EV/EBITDA
12.60x
EV/Revenue
3.41x
EV/EBIT
17.49x
EV/FCF
20.90x
Earnings Yield
4.80%
FCF Yield
5.63%
Shareholder Yield
4.44%
Graham Number
$59.83
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 23.0x earnings, MDT commands a growth premium. Graham's intrinsic value formula yields $59.83 per share, 57% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.792
NI / EBT
×
Interest Burden
0.901
EBT / EBIT
×
EBIT Margin
0.195
EBIT / Rev
×
Asset Turnover
0.407
Rev / Assets
×
Equity Multiplier
1.878
Assets / Equity
=
ROE
10.7%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. MDT's ROE of 10.7% is driven by Asset Turnover (0.407), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
14.47%
Fair P/E
37.44x
Intrinsic Value
$152.36
Price/Value
0.56x
Margin of Safety
44.41%
Premium
-44.41%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with MDT's realized 14.5% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. MDT trades at a -44% premium to its adjusted intrinsic value of $152.36, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 37.4x compares to the current market P/E of 23.0x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$93.93
Median 1Y
$91.90
5th Pctile
$60.24
95th Pctile
$140.44
Ann. Volatility
25.5%
Analyst Target
$102.09
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Geoff Martha
Chairman and Chief Executive Officer
$1,399,039 $13,672,200 $22,940,252
Thierry Piéton EVP,
Chief Financial Officer
$849,648 $3,170,470 $8,587,387
Brett Wall EVP
mer EVP & President, Neuroscience Portfolio (through June 1, 2026)
$799,519 $3,566,703 $6,921,425
Mike Marinaro EVP
& President Medical Surgical Portfolio & Americas
$819,616 $3,566,703 $6,832,836
Michelle Quinn EVP,
General Counsel and Secretary
$600,000 $3,481,600 $6,719,170

CEO Pay Ratio

185:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $22,940,252
Avg Employee Cost (SGA/emp): $124,042
Employees: 95,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
95,000
0.0% YoY
Revenue / Employee
$382,779
Rev: $36,364,000,000
Profit / Employee
$50,526
NI: $4,800,000,000
SGA / Employee
$124,042
Avg labor cost proxy
R&D / Employee
$30,242
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
ROE 9.2% 9.5% 9.7% 10.0% 8.3% 7.8% 7.2% 7.0% 7.9% 8.1% 7.2% 7.9% 8.6% 8.4% 9.5% 9.7% 9.8% 9.4% 9.8% 10.7% 10.66%
ROA 5.0% 5.2% 5.5% 5.7% 4.7% 4.4% 4.1% 4.0% 4.5% 4.5% 4.1% 4.4% 4.8% 4.7% 5.1% 5.2% 5.3% 5.1% 5.2% 5.7% 5.68%
ROIC 7.3% 7.7% 8.0% 8.2% 6.7% 6.2% 5.7% 5.5% 6.1% 6.3% 5.9% 6.1% 6.6% 6.7% 7.3% 7.4% 7.5% 7.7% 7.5% 7.8% 7.79%
ROCE 6.8% 7.3% 7.7% 8.3% 7.9% 7.5% 7.3% 7.5% 7.6% 7.7% 7.0% 7.1% 7.6% 7.7% 8.1% 8.1% 7.9% 7.7% 8.4% 9.0% 8.99%
Gross Margin 68.2% 68.3% 68.0% 65.9% 66.6% 65.2% 65.1% 65.9% 65.4% 65.6% 64.6% 65.1% 64.9% 66.5% 64.7% 57.7% 60.3% 64.9% 75.9% 65.0% 64.99%
Operating Margin 19.9% 21.4% 20.7% 15.3% 18.5% 18.0% 18.3% 16.5% 16.8% 18.3% 12.3% 16.1% 19.0% 19.9% 16.1% 16.8% 18.8% 19.7% 15.9% 18.1% 18.08%
Net Margin 16.7% 19.1% 18.4% 12.6% 5.6% 15.8% 13.8% 10.3% 11.4% 16.3% 7.6% 13.2% 15.1% 15.6% 11.8% 12.1% 15.3% 12.7% 12.7% 15.1% 15.07%
EBITDA Margin 29.4% 30.9% 30.1% 25.5% 28.8% 28.7% 28.3% 26.2% 27.1% 28.5% 19.9% 26.5% 29.1% 29.0% 25.5% 25.9% 28.1% 25.9% 26.9% 27.5% 27.51%
FCF Margin 18.2% 17.9% 18.9% 18.4% 15.7% 13.5% 14.7% 14.1% 12.7% 15.3% 16.1% 15.8% 16.7% 16.5% 15.5% 15.5% 15.0% 15.2% 14.9% 16.3% 16.33%
OCF Margin 22.5% 22.1% 23.2% 23.0% 20.4% 18.3% 19.3% 18.5% 17.4% 20.0% 21.0% 21.2% 21.8% 22.0% 21.0% 20.9% 20.5% 20.5% 20.2% 21.4% 21.40%
ROE 3Y Avg snapshot only 9.44%
ROE 5Y Avg snapshot only 9.06%
ROA 3Y Avg snapshot only 5.03%
ROIC 3Y Avg snapshot only 6.03%
ROIC Economic snapshot only 6.98%
Cash ROA snapshot only 8.61%
Cash ROIC snapshot only 11.55%
CROIC snapshot only 8.81%
NOPAT Margin snapshot only 14.43%
Pretax Margin snapshot only 17.59%
R&D / Revenue snapshot only 7.77%
SGA / Revenue snapshot only 32.43%
SBC / Revenue snapshot only 1.32%
Valuation
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
P/E Ratio 29.42 24.30 24.03 20.62 23.45 23.93 28.77 29.23 20.44 25.07 26.66 24.16 25.48 25.74 22.30 24.65 23.72 28.03 21.36 20.81 22.971
P/S Ratio 4.35 3.76 3.82 3.45 3.29 3.16 3.46 3.35 2.62 3.26 3.03 2.91 3.31 3.30 3.10 3.36 3.25 3.64 2.82 2.90 3.201
P/B Ratio 2.66 2.27 2.30 2.04 1.95 1.89 2.10 2.07 1.63 2.03 1.95 1.98 2.25 2.22 2.17 2.40 2.32 2.64 2.07 2.17 2.394
P/FCF 23.98 21.03 20.26 18.76 21.02 23.34 23.60 23.80 20.72 21.36 18.85 18.44 19.87 20.06 20.06 21.67 21.71 23.90 18.89 17.75 17.751
P/OCF 19.33 16.98 16.48 15.04 16.11 17.25 17.90 18.14 15.05 16.28 14.44 13.75 15.18 15.03 14.76 16.08 15.89 17.75 13.99 13.55 13.547
EV/EBITDA 18.31 15.27 15.34 13.50 13.11 13.11 14.31 13.90 11.47 13.72 14.03 13.87 15.14 14.83 13.40 14.49 14.20 15.93 12.48 12.60 12.595
EV/Revenue 4.82 4.20 4.25 3.92 3.78 3.71 3.99 3.89 3.17 3.78 3.55 3.53 3.93 3.87 3.68 3.96 3.85 4.20 3.33 3.41 3.414
EV/EBIT 27.05 22.11 22.18 19.29 18.82 19.01 20.74 20.02 16.54 19.60 20.71 20.35 21.89 21.46 19.43 21.16 20.88 23.75 17.70 17.49 17.490
EV/FCF 26.57 23.49 22.52 21.27 24.17 27.42 27.18 27.65 25.01 24.78 22.12 22.33 23.56 23.47 23.83 25.53 25.70 27.54 22.35 20.90 20.904
Earnings Yield 3.4% 4.1% 4.2% 4.8% 4.3% 4.2% 3.5% 3.4% 4.9% 4.0% 3.8% 4.1% 3.9% 3.9% 4.5% 4.1% 4.2% 3.6% 4.7% 4.8% 4.80%
FCF Yield 4.2% 4.8% 4.9% 5.3% 4.8% 4.3% 4.2% 4.2% 4.8% 4.7% 5.3% 5.4% 5.0% 5.0% 5.0% 4.6% 4.6% 4.2% 5.3% 5.6% 5.63%
PEG Ratio snapshot only 1.813
EV/OCF snapshot only 15.953
EV/Gross Profit snapshot only 5.120
Acquirers Multiple snapshot only 18.889
Shareholder Yield snapshot only 4.44%
Graham Number snapshot only $59.83
Leverage & Solvency
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Current Ratio 2.91 2.61 1.86 1.58 1.76 1.76 2.39 2.42 2.29 2.30 2.03 2.13 1.84 1.90 1.85 2.01 2.42 2.54 2.13 2.07 2.067
Quick Ratio 2.36 2.10 1.49 1.23 1.41 1.39 1.81 1.79 1.69 1.71 1.55 1.61 1.39 1.43 1.42 2.05 1.80 2.62 1.62 2.09 2.087
Debt/Equity 0.49 0.48 0.46 0.44 0.51 0.55 0.47 0.49 0.49 0.49 0.50 0.58 0.58 0.54 0.59 0.60 0.60 0.57 0.57 0.56 0.560
Net Debt/Equity 0.29 0.27 0.26 0.27 0.29 0.33 0.32 0.33 0.34 0.33 0.34 0.42 0.42 0.38 0.41 0.43 0.43 0.40 0.38 0.38 0.385
Debt/Assets 0.28 0.27 0.27 0.26 0.29 0.30 0.27 0.28 0.28 0.28 0.28 0.31 0.31 0.30 0.31 0.31 0.32 0.31 0.30 0.30 0.302
Debt/EBITDA 3.06 2.88 2.75 2.58 2.99 3.23 2.80 2.83 2.84 2.83 3.05 3.36 3.31 3.07 3.09 3.06 3.09 3.00 2.88 2.77 2.766
Net Debt/EBITDA 1.78 1.60 1.54 1.59 1.71 1.95 1.89 1.94 1.97 1.89 2.08 2.42 2.38 2.16 2.12 2.19 2.20 2.10 1.93 1.90 1.900
Interest Coverage 10.16 10.93 10.98 10.88 11.02 10.15 9.44 9.90 8.97 8.87 7.74 7.66 7.73 7.90 8.72 8.67 9.03 8.81 9.58 10.11 10.109
Equity Multiplier 1.76 1.75 1.73 1.71 1.80 1.83 1.77 1.77 1.75 1.75 1.79 1.87 1.86 1.82 1.91 1.90 1.88 1.87 1.88 1.86 1.858
Cash Ratio snapshot only 0.747
Debt Service Coverage snapshot only 14.037
Cash to Debt snapshot only 0.313
FCF to Debt snapshot only 0.218
Defensive Interval snapshot only 180.8 days
Efficiency & Turnover
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Asset Turnover 0.34 0.34 0.34 0.34 0.33 0.33 0.34 0.35 0.35 0.35 0.36 0.36 0.37 0.37 0.37 0.38 0.38 0.39 0.39 0.41 0.407
Inventory Turnover 2.35 2.26 2.27 2.21 2.15 2.09 2.16 2.07 2.05 2.01 2.13 2.05 2.05 2.03 2.18 4.96 2.25 5.62 2.23 — —
Receivables Turnover 5.87 5.96 5.75 5.79 5.54 5.43 5.41 5.68 5.53 5.45 5.34 5.51 5.41 5.50 5.31 5.57 5.50 11.44 5.53 11.57 11.575
Payables Turnover 5.43 5.37 4.63 4.98 4.91 4.93 4.34 4.90 5.06 5.31 4.42 5.01 5.07 5.39 4.79 5.16 5.29 5.56 5.00 4.76 4.764
DSO 62 61 63 63 66 67 67 64 66 67 68 66 67 66 69 65 66 32 66 32 31.5 days
DIO 155 161 161 165 170 175 169 177 178 182 171 178 178 179 168 74 162 65 164 -9 -8.9 days
DPO 67 68 79 73 74 74 84 74 72 69 83 73 72 68 76 71 69 66 73 77 76.6 days
Cash Conversion Cycle 150 155 145 155 161 168 152 166 172 180 157 172 173 178 160 68 159 31 157 -54 -54.0 days
Cash Velocity snapshot only 4.257
Capital Intensity snapshot only 2.485
Growth (YoY)
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Revenue 14.1% 13.8% 5.2% -1.7% -3.1% -3.2% -1.4% 1.6% 3.7% 5.0% 3.6% 3.2% 3.3% 2.7% 3.6% 5.0% 5.3% 6.9% 8.4% 9.8% 9.77%
Net Income 33.0% 70.0% 39.7% 34.0% -8.2% -17.3% -25.4% -30.5% -5.1% 3.4% -2.2% 8.5% 4.6% 1.4% 26.8% 18.7% 11.1% 8.3% 2.9% 12.2% 12.21%
EPS 32.7% 70.7% 41.1% 36.2% -6.6% -16.2% -24.8% -30.4% -5.1% 3.4% -1.6% 11.6% 8.2% 5.0% 30.6% 19.6% 11.1% 8.1% 2.9% 12.4% 12.38%
FCF 21.5% 22.6% 22.4% -2.3% -16.5% -26.6% -23.4% -22.3% -16.1% 18.4% 13.5% 15.8% 35.9% 10.9% -0.3% 3.1% -5.3% -1.0% 4.6% 15.6% 15.63%
EBITDA 28.4% 41.6% 16.7% 16.4% 6.1% -0.3% -0.9% -1.9% -0.8% 2.2% -5.7% -6.3% -2.9% -2.8% 12.4% 12.8% 10.1% 8.1% 5.4% 8.9% 8.89%
Op. Income 49.1% 77.9% 28.2% 28.8% 10.5% -1.7% -4.6% -6.5% -5.0% 1.1% -6.2% -8.4% -2.8% -1.5% 15.8% 18.8% 14.8% 13.8% 8.6% 10.8% 10.85%
OCF Growth snapshot only 12.44%
Asset Growth snapshot only 2.57%
Equity Growth snapshot only 4.88%
Debt Growth snapshot only -1.59%
Shares Change snapshot only -0.16%
Dividend Growth snapshot only 1.52%
Growth (CAGR)
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Revenue 3Y 1.5% 1.3% 1.2% 0.4% -0.1% -0.3% 2.6% 4.2% 4.7% 5.0% 2.4% 1.0% 1.2% 1.5% 1.9% 3.3% 4.1% 4.9% 5.2% 6.0% 5.96%
Revenue 5Y 1.9% 1.6% 1.3% 0.7% 0.8% 0.7% 0.8% 1.1% 1.0% 1.1% 1.2% 1.2% 1.3% 1.3% 3.0% 4.1% 4.5% 4.9% 3.8% 3.5% 3.51%
EPS 3Y 27.8% 0.0% 3.0% 6.1% -2.1% -8.1% -7.4% -6.0% 5.6% 13.9% 1.5% 1.9% -1.4% -3.1% -1.1% -2.4% 4.5% 5.5% 9.8% 14.5% 14.47%
EPS 5Y 2.6% 4.9% 5.1% 5.4% -2.5% 8.0% 4.4% 3.2% 13.1% -2.8% -4.2% -1.5% -0.7% -3.4% 0.4% 2.1% 7.2% 10.9% 7.0% 7.3% 7.29%
Net Income 3Y 27.7% -0.0% 2.9% 5.6% -2.5% -8.6% -7.8% -6.4% 5.1% 13.3% 0.6% 0.4% -3.0% -4.7% -2.6% -3.6% 3.3% 4.3% 8.5% 13.1% 13.06%
Net Income 5Y 2.1% 4.4% 4.6% 4.8% -2.9% 7.7% 3.9% 2.7% 12.6% -3.1% -4.5% -2.3% -1.7% -4.3% -0.5% 1.1% 6.1% 9.8% 5.9% 6.1% 6.14%
EBITDA 3Y -2.4% -2.2% -1.9% -1.6% -1.6% -2.7% 3.7% 8.1% 10.6% 13.0% 2.9% 2.3% 0.7% -0.3% 1.6% 1.2% 2.0% 2.4% 3.8% 4.8% 4.81%
EBITDA 5Y -0.7% 0.6% 0.4% 0.8% 1.3% 0.9% 0.3% 0.5% -0.4% -0.9% -2.5% -2.6% -1.7% -1.7% 3.4% 6.0% 7.6% 8.7% 5.3% 5.6% 5.63%
Gross Profit 3Y 0.1% 0.1% 0.2% -0.5% -1.1% -1.5% 1.7% 4.1% 5.1% 5.9% 2.5% 0.3% 0.1% 0.1% 0.6% 1.1% 1.5% 2.5% 4.9% 6.5% 6.50%
Gross Profit 5Y 1.5% 1.4% 1.1% 0.4% 0.2% -0.2% -0.4% -0.3% -0.5% -0.3% -0.2% -0.1% 0.1% 0.2% 2.4% 3.4% 3.8% 4.3% 3.8% 3.6% 3.56%
Op. Income 3Y -4.8% -3.1% -2.8% -2.6% -2.5% -4.5% 4.6% 12.3% 16.1% 21.0% 4.7% 3.3% 0.7% -0.7% 1.2% 0.6% 2.0% 4.3% 5.6% 6.4% 6.43%
Op. Income 5Y -0.4% 1.8% 1.5% 1.7% -0.7% -2.5% -3.8% -2.8% -2.0% -2.0% -3.9% -4.6% -3.1% -2.8% 4.4% 9.0% 11.8% 14.7% 7.6% 7.8% 7.76%
FCF 3Y 5.9% 5.3% 0.6% 0.3% -8.5% -14.5% -8.7% -2.2% -5.2% 2.1% 2.1% -4.2% -1.6% -1.3% -4.6% -2.5% 2.6% 9.1% 5.8% 11.3% 11.33%
FCF 5Y 3.1% 1.9% 1.2% 3.3% 2.2% -0.7% 4.8% -0.5% -3.6% 0.3% -2.4% -1.9% -2.7% -3.9% -2.9% 2.2% 1.8% 3.2% 2.1% 0.9% 0.93%
OCF 3Y 6.6% 5.7% 1.6% 1.6% -5.8% -10.5% -5.8% -1.0% -2.4% 2.9% 2.8% -1.7% 0.2% 1.2% -1.4% 0.0% 4.2% 8.9% 6.7% 11.3% 11.28%
OCF 5Y 3.1% 1.8% 1.3% 3.3% 2.7% 0.8% 5.2% 0.6% -1.2% 1.7% -0.6% 0.2% -0.9% -1.5% -0.5% 3.6% 3.5% 4.1% 3.3% 2.1% 2.07%
Assets 3Y 1.3% 1.1% 0.5% -0.5% 0.8% 0.5% 0.1% -1.1% -2.1% -2.3% -1.1% -0.8% -0.6% -0.7% 0.3% 0.4% -0.7% -0.9% 0.8% 0.9% 0.92%
Assets 5Y -1.4% -1.2% -1.8% -2.1% -0.3% -0.4% -0.1% 0.2% 0.4% 0.5% 0.1% -0.3% -0.2% -0.6% 0.2% -0.6% -1.0% -1.2% -0.0% 0.3% 0.33%
Equity 3Y 1.6% 1.8% 1.6% 1.5% 0.9% -0.2% 0.5% 0.6% 0.9% 0.7% -0.8% -2.3% -2.3% -2.0% -3.0% -3.1% -2.1% -1.6% -1.3% -0.6% -0.62%
Book Value 3Y 1.7% 1.8% 1.8% 1.9% 1.3% 0.2% 0.9% 1.0% 1.4% 1.3% 0.0% -0.9% -0.6% -0.4% -1.5% -1.9% -1.0% -0.5% -0.2% 0.6% 0.62%
Dividend 3Y 2.9% 2.8% 2.9% 3.0% 2.9% 2.8% 2.7% 2.2% 1.9% 1.6% 1.3% 1.7% 1.6% 1.1% 0.7% 0.8% 1.0% 1.3% 1.6% 1.7% 1.70%
Growth Quality
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Revenue Stability 0.11 0.07 0.26 0.10 0.11 0.08 0.46 0.33 0.25 0.25 0.61 0.70 0.56 0.55 0.91 0.98 0.99 0.99 0.89 0.73 0.727
Earnings Stability 0.00 0.07 0.23 0.36 0.02 0.04 0.05 0.09 0.29 0.11 0.29 0.11 0.01 0.02 0.02 0.00 0.31 0.27 0.16 0.17 0.167
Margin Stability 0.97 0.96 0.97 0.98 0.97 0.97 0.97 0.97 0.97 0.96 0.97 0.97 0.97 0.98 0.98 0.98 0.97 0.97 1.00 0.98 0.980
Rev. Growth Consistency 0.50 0.50 1.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Earn. Growth Consistency 0.50 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.50 0.50 1.00 0.50 1.00 1.00 1.00 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.87 0.50 0.84 0.86 0.97 0.93 0.90 0.88 0.98 0.99 0.99 0.97 0.98 0.99 0.89 0.93 0.96 0.97 0.99 0.95 0.951
Earnings Smoothness 0.72 0.48 0.67 0.71 0.91 0.81 0.71 0.64 0.95 0.97 0.98 0.92 0.96 0.99 0.76 0.83 0.89 0.92 0.97 0.88 0.885
ROE Trend 0.01 0.01 0.01 0.02 0.00 0.00 -0.01 -0.02 -0.01 -0.01 -0.01 -0.00 0.01 0.01 0.02 0.02 0.01 0.01 0.01 0.01 0.015
Gross Margin Trend 0.00 0.01 0.02 0.01 0.01 0.01 -0.01 -0.01 -0.02 -0.02 -0.01 -0.01 -0.01 -0.01 -0.00 -0.02 -0.03 -0.03 -0.00 0.02 0.024
FCF Margin Trend -0.01 -0.01 0.00 0.01 -0.02 -0.04 -0.03 -0.04 -0.04 -0.00 -0.01 -0.00 0.03 0.02 0.00 0.01 0.00 -0.01 -0.01 0.01 0.007
Sustainable Growth Rate 2.8% 3.1% 3.2% 3.4% 1.6% 1.0% 0.3% -0.0% 0.9% 1.1% 0.0% 0.6% 1.3% 1.3% 2.2% 2.2% 2.4% 2.0% 2.4% 3.2% 3.22%
Internal Growth Rate 1.6% 1.7% 1.8% 2.0% 0.9% 0.6% 0.2% — 0.5% 0.6% 0.0% 0.3% 0.7% 0.7% 1.2% 1.2% 1.3% 1.1% 1.3% 1.7% 1.74%
Cash Flow Quality
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
OCF/Net Income 1.52 1.43 1.46 1.37 1.46 1.39 1.61 1.61 1.36 1.54 1.85 1.76 1.68 1.71 1.51 1.53 1.49 1.58 1.53 1.54 1.536
FCF/OCF 0.81 0.81 0.81 0.80 0.77 0.74 0.76 0.76 0.73 0.76 0.77 0.75 0.76 0.75 0.74 0.74 0.73 0.74 0.74 0.76 0.763
FCF/Net Income snapshot only 1.172
OCF/EBITDA snapshot only 0.790
CapEx/Revenue 4.4% 4.3% 4.3% 4.6% 4.8% 4.8% 4.7% 4.4% 4.8% 4.8% 4.9% 5.4% 5.1% 5.5% 5.5% 5.4% 5.5% 5.3% 5.2% 5.1% 5.07%
CapEx/Depreciation snapshot only 0.668
Accruals Ratio -0.03 -0.02 -0.03 -0.02 -0.02 -0.02 -0.03 -0.02 -0.02 -0.02 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03 -0.03 -0.030
Sloan Accruals snapshot only -0.021
Cash Flow Adequacy snapshot only 1.447
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Dividend Yield 2.4% 2.8% 2.8% 3.2% 3.5% 3.7% 3.3% 3.4% 4.3% 3.5% 3.7% 3.8% 3.3% 3.3% 3.5% 3.1% 3.2% 2.8% 3.5% 3.4% 3.04%
Dividend/Share $2.40 $2.46 $2.52 $2.58 $2.63 $2.67 $2.71 $2.72 $2.74 $2.75 $2.77 $2.81 $2.82 $2.80 $2.79 $2.80 $2.81 $2.82 $2.83 $2.84 $2.86
Payout Ratio 69.2% 67.6% 67.1% 66.1% 80.9% 87.5% 96.2% 1.0% 88.9% 87.1% 99.7% 92.8% 84.5% 84.6% 77.0% 77.3% 75.8% 78.6% 75.8% 69.8% 69.79%
FCF Payout Ratio 56.4% 58.5% 56.6% 60.1% 72.5% 85.3% 79.0% 81.7% 90.1% 74.2% 70.5% 70.9% 65.9% 65.9% 69.2% 67.9% 69.4% 67.1% 67.1% 59.5% 59.52%
Total Payout Ratio 97.4% 1.0% 1.2% 1.2% 1.3% 1.4% 1.1% 1.1% 1.0% 1.0% 1.6% 2.1% 1.9% 1.9% 1.5% 95.8% 95.8% 97.6% 97.4% 92.3% 92.33%
Div. Increase Streak 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0
Chowder Number 0.11 0.11 0.11 0.11 0.11 0.11 0.10 0.09 0.09 0.06 0.05 0.04 0.03 0.02 0.01 0.02 0.03 0.03 0.05 0.05 0.047
Buyback Yield 1.0% 1.4% 2.1% 2.4% 2.2% 2.0% 0.6% 0.4% 0.7% 0.6% 2.2% 4.7% 4.2% 4.2% 3.1% 0.8% 0.8% 0.7% 1.0% 1.1% 1.08%
Net Buyback Yield 0.5% 1.0% 1.7% 2.1% 1.9% 1.7% 0.3% 0.1% 0.3% 0.3% 1.9% 4.4% 3.8% 3.7% 2.6% 0.3% 0.4% 0.3% 0.5% 0.7% 0.68%
Total Shareholder Return 2.9% 3.8% 4.5% 5.3% 5.4% 5.4% 3.7% 3.5% 4.6% 3.8% 5.6% 8.3% 7.1% 7.0% 6.1% 3.4% 3.6% 3.1% 4.1% 4.0% 4.03%
DuPont Factors
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Tax Burden (NI/EBT) 0.92 0.90 0.91 0.91 0.77 0.75 0.70 0.66 0.75 0.76 0.76 0.80 0.83 0.82 0.83 0.82 0.84 0.83 0.78 0.79 0.792
Interest Burden (EBT/EBIT) 0.90 0.91 0.91 0.91 0.91 0.90 0.89 0.90 0.89 0.89 0.87 0.87 0.87 0.87 0.89 0.88 0.89 0.89 0.90 0.90 0.901
EBIT Margin 0.18 0.19 0.19 0.20 0.20 0.20 0.19 0.19 0.19 0.19 0.17 0.17 0.18 0.18 0.19 0.19 0.18 0.18 0.19 0.20 0.195
Asset Turnover 0.34 0.34 0.34 0.34 0.33 0.33 0.34 0.35 0.35 0.35 0.36 0.36 0.37 0.37 0.37 0.38 0.38 0.39 0.39 0.41 0.407
Equity Multiplier 1.84 1.83 1.77 1.74 1.78 1.79 1.75 1.74 1.77 1.79 1.78 1.82 1.80 1.79 1.85 1.89 1.87 1.84 1.89 1.88 1.878
Per Share
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
EPS (Diluted TTM) $3.47 $3.64 $3.75 $3.90 $3.24 $3.05 $2.82 $2.71 $3.08 $3.15 $2.77 $3.03 $3.33 $3.31 $3.62 $3.62 $3.70 $3.58 $3.73 $4.07 $4.07
Book Value/Share $38.36 $38.91 $39.07 $39.47 $38.95 $38.62 $38.63 $38.37 $38.64 $38.89 $37.89 $36.98 $37.68 $38.40 $37.29 $37.21 $37.79 $38.03 $38.40 $39.09 $39.73
Tangible Book/Share $-4.53 $-3.62 $-2.64 $-2.57 $-3.15 $-4.05 $-3.59 $-3.52 $-2.57 $-2.30 $-3.02 $-4.59 $-3.96 $-2.81 $-4.18 $-4.15 $-3.05 $-2.52 $-2.54 $-2.48 $-2.48
Revenue/Share $23.46 $23.54 $23.56 $23.28 $23.13 $23.10 $23.43 $23.66 $23.99 $24.27 $24.42 $25.13 $25.64 $25.81 $26.04 $26.57 $27.00 $27.55 $28.23 $29.21 $29.33
FCF/Share $4.26 $4.20 $4.44 $4.29 $3.62 $3.13 $3.44 $3.33 $3.04 $3.70 $3.92 $3.97 $4.27 $4.25 $4.03 $4.12 $4.04 $4.20 $4.21 $4.77 $4.79
OCF/Share $5.28 $5.21 $5.46 $5.35 $4.72 $4.23 $4.53 $4.37 $4.18 $4.86 $5.12 $5.32 $5.59 $5.67 $5.47 $5.55 $5.52 $5.66 $5.69 $6.25 $6.28
Cash/Share $7.87 $8.31 $7.86 $6.65 $8.58 $8.36 $5.97 $5.90 $5.81 $6.25 $6.04 $6.05 $6.21 $6.16 $6.96 $6.31 $6.47 $6.51 $7.16 $6.86 $6.89
EBITDA/Share $6.18 $6.47 $6.53 $6.75 $6.67 $6.54 $6.53 $6.63 $6.62 $6.69 $6.19 $6.39 $6.65 $6.73 $7.16 $7.26 $7.32 $7.26 $7.54 $7.92 $7.92
Debt/Share $18.91 $18.63 $17.93 $17.39 $19.98 $21.12 $18.28 $18.73 $18.83 $18.91 $18.88 $21.49 $22.01 $20.69 $22.14 $22.23 $22.60 $21.79 $21.71 $21.91 $21.91
Net Debt/Share $11.03 $10.32 $10.07 $10.74 $11.40 $12.76 $12.31 $12.83 $13.02 $12.66 $12.84 $15.44 $15.80 $14.53 $15.18 $15.92 $16.13 $15.28 $14.55 $15.04 $15.04
Academic Models
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.860
Altman Z-Prime snapshot only 5.265
Piotroski F-Score 8 9 8 6 4 4 5 7 7 9 5 6 6 7 7 6 6 6 8 9 9
Beneish M-Score -2.61 -2.58 -2.60 -2.61 -2.56 -2.46 -2.49 -2.50 -2.49 -2.59 -2.64 -2.61 -2.58 -2.63 -2.54 -2.45 -2.55 -3.38 -2.67 -3.44 -3.444
Ohlson O-Score snapshot only -9.522
Net-Net WC snapshot only $-14.06
EVA snapshot only $-1540543661.97
Credit
Metric Trend Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Q1'27 Current
Credit Rating snapshot only A
Credit Score 80.98 82.06 79.80 74.83 74.80 67.25 73.57 72.85 73.29 73.10 73.44 71.65 70.40 70.74 69.93 72.32 71.66 77.90 73.47 74.10 74.096
Credit Grade snapshot only 6
Credit Trend snapshot only 1.779
Implied Spread (bps) snapshot only 150.000
Industry Credit Rank snapshot only 69
Sector Credit Rank snapshot only 62

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms